Cargando…

Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM

[Image: see text] Anti-spike neutralizing antibodies (S NAbs) have been developed for prevention and treatment against COVID-19. The nanoscopic characterization of the dynamic interaction between spike proteins and S NAbs remains difficult. By using high-speed atomic force microscopy (HS-AFM), we el...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Keesiang, Nishide, Goro, Sajidah, Elma Sakinatus, Yamano, Tomoyoshi, Qiu, Yujia, Yoshida, Takeshi, Kobayashi, Akiko, Hazawa, Masaharu, Ando, Toshio, Hanayama, Rikinari, Wong, Richard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881159/
https://www.ncbi.nlm.nih.gov/pubmed/36641798
http://dx.doi.org/10.1021/acs.nanolett.2c04270
_version_ 1784879054436958208
author Lim, Keesiang
Nishide, Goro
Sajidah, Elma Sakinatus
Yamano, Tomoyoshi
Qiu, Yujia
Yoshida, Takeshi
Kobayashi, Akiko
Hazawa, Masaharu
Ando, Toshio
Hanayama, Rikinari
Wong, Richard W.
author_facet Lim, Keesiang
Nishide, Goro
Sajidah, Elma Sakinatus
Yamano, Tomoyoshi
Qiu, Yujia
Yoshida, Takeshi
Kobayashi, Akiko
Hazawa, Masaharu
Ando, Toshio
Hanayama, Rikinari
Wong, Richard W.
author_sort Lim, Keesiang
collection PubMed
description [Image: see text] Anti-spike neutralizing antibodies (S NAbs) have been developed for prevention and treatment against COVID-19. The nanoscopic characterization of the dynamic interaction between spike proteins and S NAbs remains difficult. By using high-speed atomic force microscopy (HS-AFM), we elucidate the molecular property of an S NAb and its interaction with spike proteins. The S NAb appeared as monomers with a Y conformation at low density and formed hexameric oligomers at high density. The dynamic S NAb–spike protein interaction at RBD induces neither RBD opening nor S1 subunit shedding. Furthermore, the interaction was stable at endosomal pH. These findings indicated that the S NAb could have a negligible risk of antibody-dependent enhancement. Dynamic movement of spike proteins on small extracellular vesicles (S sEV) resembled that on SARS-CoV-2. The sensitivity of variant S sEVs to S NAb could be evaluated using HS-AFM. Altogether, we demonstrate a nanoscopic assessment platform for evaluating the binding property of S NAbs.
format Online
Article
Text
id pubmed-9881159
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-98811592023-01-28 Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM Lim, Keesiang Nishide, Goro Sajidah, Elma Sakinatus Yamano, Tomoyoshi Qiu, Yujia Yoshida, Takeshi Kobayashi, Akiko Hazawa, Masaharu Ando, Toshio Hanayama, Rikinari Wong, Richard W. Nano Lett [Image: see text] Anti-spike neutralizing antibodies (S NAbs) have been developed for prevention and treatment against COVID-19. The nanoscopic characterization of the dynamic interaction between spike proteins and S NAbs remains difficult. By using high-speed atomic force microscopy (HS-AFM), we elucidate the molecular property of an S NAb and its interaction with spike proteins. The S NAb appeared as monomers with a Y conformation at low density and formed hexameric oligomers at high density. The dynamic S NAb–spike protein interaction at RBD induces neither RBD opening nor S1 subunit shedding. Furthermore, the interaction was stable at endosomal pH. These findings indicated that the S NAb could have a negligible risk of antibody-dependent enhancement. Dynamic movement of spike proteins on small extracellular vesicles (S sEV) resembled that on SARS-CoV-2. The sensitivity of variant S sEVs to S NAb could be evaluated using HS-AFM. Altogether, we demonstrate a nanoscopic assessment platform for evaluating the binding property of S NAbs. American Chemical Society 2023-01-15 /pmc/articles/PMC9881159/ /pubmed/36641798 http://dx.doi.org/10.1021/acs.nanolett.2c04270 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Lim, Keesiang
Nishide, Goro
Sajidah, Elma Sakinatus
Yamano, Tomoyoshi
Qiu, Yujia
Yoshida, Takeshi
Kobayashi, Akiko
Hazawa, Masaharu
Ando, Toshio
Hanayama, Rikinari
Wong, Richard W.
Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM
title Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM
title_full Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM
title_fullStr Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM
title_full_unstemmed Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM
title_short Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM
title_sort nanoscopic assessment of anti-sars-cov-2 spike neutralizing antibody using high-speed afm
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881159/
https://www.ncbi.nlm.nih.gov/pubmed/36641798
http://dx.doi.org/10.1021/acs.nanolett.2c04270
work_keys_str_mv AT limkeesiang nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT nishidegoro nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT sajidahelmasakinatus nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT yamanotomoyoshi nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT qiuyujia nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT yoshidatakeshi nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT kobayashiakiko nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT hazawamasaharu nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT andotoshio nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT hanayamarikinari nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm
AT wongrichardw nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm